FOXP2 and diffuse large B-cell lymphoma: Increased frequency of FOXP2 expression identified patients with significantly inferior OS in both the GCB (P = 0.0331) and non-GCB (P = 0.0475) subgroups of DLBCL patients (Figure 3C–3D).